Dr. David A. Scheinberg

Member/Professor Molecular Pharmacology
Affiliations

Memorial Sloan Kettering CC

Research Summary

The overall goals of this laboratory are to develop novel targeted immunotherapies based on effectors of the immune system and to understand their mechanisms of action as well as the mechanisms of resistance to them. This includes antibodies, targeted nano-devices, engineered cells, and active specific agents such vaccines. An important goal is to take these new therapies into human clinical trials for testing. Examples include a molecular nanogenerator that releases alpha particles inside cancer cells, now being tested in Phase II human trials and a vaccine to WT1 about to enter Phase III trials.

Website
Research Topics

Nanomedicine

Nanochemistry

Nanobiotechnology

Want to get in touch with Nanotech New York?

Be #Nanofabulous 

  • Twitter Social Icon
  • Instagram
  • m_swarm_630x630
  • Facebook Social Icon
  • LinkedIn Social Icon